Derm-Biome Pharmaceuticals
PrivateLast Round
Grant
May 8, 2024
Total Funding Raised
$328,000
Company Overview
Derm-Biome Pharmaceuticals operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Grant round in May 2024.
Derm-Biome Pharmaceuticals is a biotechnology company that develops novel topical therapies for inflammatory skin diseases, precancerous skin conditions, and aging skin.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Derm-Biome Pharmaceuticals Comparables
Compare Derm-Biome Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DFB Pharmaceuticals | 79% | |
| Vertes Therapeutics | 79% | |
| Vidac Pharma Holding PLC | 78% |
For institutional investors. Book with your work email.
Derm-Biome Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 8, 2024 | ||||
| Seed | Apr 17, 2024 | ||||
| Pre Seed | Jul 2, 2020 |
For institutional investors. Book with your work email.
Derm-Biome Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Natural Sciences and Engineering Research Council of Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 8, 2024
$328K grant received from Canadian government agencies.
For institutional investors. Book with your work email.
Derm-Biome Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Derm-Biome Pharmaceuticals's valuation, stock price, and market status.
Is Derm-Biome Pharmaceuticals a public or private company?
Derm-Biome Pharmaceuticals is a private company.
What is the current stock price of Derm-Biome Pharmaceuticals?
Derm-Biome Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Derm-Biome Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Derm-Biome Pharmaceuticals worth (valuation)?
Valuation information for Derm-Biome Pharmaceuticals is not publicly available.
Can I buy Derm-Biome Pharmaceuticals stock?
Derm-Biome Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Derm-Biome Pharmaceuticals's last funding round?
Derm-Biome Pharmaceuticals's most recent funding round was Grant on May 8, 2024.
Who are the main investors in Derm-Biome Pharmaceuticals?
Key investors in Derm-Biome Pharmaceuticals include Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada.
Will Derm-Biome Pharmaceuticals IPO soon?
No public IPO plans have been announced for Derm-Biome Pharmaceuticals.
How can I track Derm-Biome Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Derm-Biome Pharmaceuticals's shares on secondary markets.